AzTrials
AzTrials

Abdominal TraumaPhase 3NCT02952976

Study of Primary Fascial Closure Rate in Patients With Open Abdomen Treated With Abthera Versus Barker Technique

A Phase 3 study testing Abthera and Barker in people with Abdominal Trauma and Abdominal Sepsis, run by Sociedade Brasileira de Atendimento Integrado ao Trauma.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

This study is being done to compare two different Temporary Abdominal Closure methods that could be used in cases like yours. The methods being compared are the Barker's vacuum packing technique (BVPT) and the Open Abdomen Negative Pressure Therapy System (ABThera). Read more about this study

Who is it for?
Ages 18 years and older
What is being tested?
Abthera and Barker
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
94 participants
Where
No sites listed yet
Study dates
1 Jul 2017to Dec 2019
Phase
Phase 3
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Patients with indication of an open abdomen According to the Attending physician
  • Damage control surgery in trauma patients,
  • Patients with abdominal compartment syndrome,
  • Septic shock patients requiring short surgery and inability to close the abdominal cavity.

Who cannot join

  • Pregnancy;
  • Chronic renal impairment,
  • Child-Pugh C,
  • Body index over 40 kg / m2,
  • Uncontrolled bleeding during laparotomy
  • Patients progressing to death within the first 48 hours

Trial locations and contacts

No sites are listed yet.

Diogo Garcia, MD PhD FACS contact

+5511996131077

diogogarcia@me.com

About this study

This study is being done to compare two different Temporary Abdominal Closure methods that could be used in cases like yours. The methods being compared are the Barker's vacuum packing technique (BVPT) and the Open Abdomen Negative Pressure Therapy System (ABThera).

Read the detailed description

This study is being done to compare two different Temporary Abdominal Closure methods that could be used in cases of open abdomen. The methods being compared are the Barker's vacuum packing technique (BVPT) and the Open Abdomen Negative Pressure Therapy System (ABThera). The BVPT will be made up by an internal plastic layer to cover abdominal viscera, a second layer with surgical sponges and a suction drain and will be covered by an adhesive plastic layer. Then the dressing will be connected to the hospital's vacuum system. The ABThera dressing is available commercially.

Study Participants Enrollment will happen at the operating room

Investigator will include in this study patients who have the following indications to laparostomy:

  • Damage control surgery in trauma patients,
  • Patients with abdominal compartment syndrome,
  • Septic shock patients requiring short surgery and inability to close the abdominal cavity.

Signing the consent form will be held in order of preference by:

  1. Patient
  2. Legal representative
  3. Doctor appointed by the hospital that does not participate in the study(only in cases where the urgency of the surgery do not allow contact with the representatives). In the latter case the signature of the term should be applied to the legal representative as soon as possible. Criteria for inclusion and exclusion: Inclusion:
  • Patients with indication of an open abdomen According to the Attending physician (above criteria) Exclusion:
  • Pregnancy;
  • Chronic renal impairment,
  • Child-Pugh C,
  • Body index over 40 kg / m2,
  • Uncontrolled bleeding during laparotomy
  • Patients progressing to death within the first 48 hours Allocation Concealment and Randomization Randomization will be performed by central online dedicated site in the ratio of 1: 1. When a patient is eligible, a surgeon will access the Web site, enter patient's information to know the assigned allocation. Variable block size randomization will be utilized stratified by study center Assuming a closure rate of 75% in the Abthera arm and 35% in the Control arm, a study with 36 patients in each treatment arm (72 total) would have 90% power to detect such a difference at the 0.05 significance level. In order to evaluate closure for 36 patients in each arm, with an estimated loss of 30% either by withdraw or death prior to 48h. So the study will enroll 94 patients (47 in each treatment group) After surgery, patients will be referred to the intensive care unit (ICU). In patients' Barker Group a fenestrated plastic will be used and that will be in contact with viscera followed by four pads with a suction drain and an adhesive finishing layer. In ABThera group technique the dressing will be done according to the description and the manufacturer's instructions (Acelity, San Antonio, TX). Primary Objective :
  • Fascial closure in 30 days Secondary objectives
  • Demographic variables (gender, age, comorbidities, mechanism of injury or disease),
  • Indication of laparostomy,
  • Systolic blood pressure,
  • Amount of fluid drained by the healing of laparostomy,
  • Amount of crystalloid,
  • Amount of hemoconcentrated,
  • APACHE II ICU admission,
  • Length of stay in the ICU,
  • Length of mechanical ventilation,
  • Length of hospital stay,
  • Time to closure
  • Adverse Events
  • Complications
  • Mortality. In trauma patients the score Revised Trauma (RTS) and the Injury Severity Score (ISS) will be calculated Statistical analysis Descriptive variables will be summarized as frequencies and percentages. Continuous variable data will be presented as means and standard deviations or medians and ranges, depending on the distribution. The analysis of the qualitative variables will be done through measures of association (chi-square or Fisher 's exact test). The analysis of quantitative variables will be made by means of different tests (parametric and nonparametric) depending on the outcome of the applied normality test
Being tested
Abthera, Barker
Keywords
open abdomen, Damage control, Abdominal Compartment Syndrome
Medical subject headings
Abdominal Injuries, Intraabdominal Infections, Intra-Abdominal Hypertension

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • AbtheraDevice

    ABThera group technique the dressing will be done according to the description and the manufacturer's instructions (Acelity, San Antonio, TX).

  • BarkerDevice

    In Barker Group a fenestrated plastic will be used and that will be in contact with viscera followed by four pads with a suction drain and an adhesive finishing layer.

Study groups in NCT02952976
Study groupRoleWhat they receive
AbtheraActive comparatorPatients with open abdomen submitted to treatment with the Abthera dressing
Receives: Device: Abthera
BarkerActive comparatorPatients with open abdomen submitted to treatment with the Baker dressing
Receives: Device: Barker

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. 30 day fascial closure

    Percentage of facial closure in each arm

    Measured: 30 day

Secondary outcomes (2)
  1. Mortality

    Percentage of mortality closure in each arm

    Measured: 30 days

  2. Drainage

    Amount of fluid in ml drained by the dressing

    Measured: 30 days

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted2 Nov 2016 (estimated)
  2. Study start1 Jul 2017 (estimated)
  3. Primary completionJul 2019 (estimated)
  4. Study completionDec 2019 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase 3
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
94 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02952976
Sponsor's protocol ID
number1-oct-2016
Status last verified
Apr 2017
First submitted
28 Oct 2016
Last updated
25 Apr 2017
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
Yes
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A Phase 3 study testing Abthera and Barker in people with Abdominal Trauma and Abdominal Sepsis, run by Sociedade Brasileira de Atendimento Integrado ao Trauma.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 25 Apr 2017. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

What does this phase mean?

Phase 3 studies compare the treatment with the current standard treatment or a placebo in a large group, to confirm how well it works and watch for side effects.

Not every study follows the same path, and some studies (observational studies, device studies) have no phase.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Diogo Garcia, MD PhD FACS (+5511996131077, diogogarcia@me.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

30 day fascial closure (time frame: 30 day). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 25 Apr 2017.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in